BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/9/2024 8:41:19 AM | Browse: 99 | Download: 229
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 96022
Country China
Received
2024-04-24 16:05
Peer-Review Started
2024-04-24 16:05
To Make the First Decision
Return for Revision
2024-06-27 20:24
Revised
2024-06-30 01:40
Second Decision
2024-07-24 02:36
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief
2024-07-24 07:23
Articles in Press
2024-07-24 07:23
Publication Fee Transferred
2024-07-29 13:05
Edit the Manuscript by Language Editor
Typeset the Manuscript
2024-08-14 02:45
Publish the Manuscript Online
2024-09-09 08:41
ISSN 1948-5204 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Review
Article Title Erythropoietin-induced hepatocyte receptor A2 regulates effect of pyroptosis on gastrointestinal colorectal cancer occurrence and metastasis resistance
Manuscript Source Unsolicited Manuscript
All Author List Yu-Kun Zhang, Ran Shi, Ruo-Yu Meng, Shui-Li Lin and Mei Zheng
ORCID
Author(s) ORCID Number
Mei Zheng http://orcid.org/0009-0000-2180-9552
Funding Agency and Grant Number
Funding Agency Grant Number
Scientific Research Nurturing Fund of the First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital QYPY2020NSFC0609
Corresponding Author Mei Zheng, PhD, Doctor, Doctor, Department of Rehabilitation Medicine, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, No. 16766 Jingshi Road, Jinan 250014, Shandong Province, China. 17686689905@163.com
Key Words Colorectal cancer; Pyroptosis; Erythropoietin-induced hepatocyte receptor A2; Tumor metastasis; Drug resistance
Core Tip This study investigated the expression of erythropoietin-induced hepatocyte receptor A2 (EphA2) in gastrointestinal (GI) colorectal cancer (CRC) and the mechanism by which EphA2 regulates pyroptosis. By reviewing the relevant literature, we found that EphA2 regulates pyroptosis through a variety of signaling pathways (such as the phosphatidylinositol 3 kinase/protein kinase B and Ras/mitogen-activated protein kinase pathways), thereby affecting the survival, proliferation and metastasis of cancer cells. The abnormal expression of EphA2 is closely related to the malignant behavior of GI CRC, and EphA2 further regulates the tumor microenvironment and immune response through interactions with inflammatory factors (such as tumor necrosis factor-α and interferon-γ). Studies have shown that targeting EphA2 can induce pyrodeath in cells, improve the sensitivity of cancer cells to treatment, and subsequently inhibit the occurrence and metastasis of tumors. Therefore, an in-depth understanding of the molecular mechanism by which EphA2 regulates pyrodeath provides new ideas and potential targets for the treatment of GI CRC.
Publish Date 2024-09-09 08:41
Citation <p>Zhang YK, Shi R, Meng RY, Lin SL, Zheng M. Erythropoietin-induced hepatocyte receptor A2 regulates effect of pyroptosis on gastrointestinal colorectal cancer occurrence and metastasis resistance. <i>World J Gastrointest Oncol</i> 2024; 16(9): 3781-3797</p>
URL https://www.wjgnet.com/1948-5204/full/v16/i9/3781.htm
DOI https://dx.doi.org/10.4251/wjgo.v16.i9.3781
Full Article (PDF) WJGO-16-3781-with-cover.pdf
Manuscript File 96022_Auto_Edited_073505.docx
Answering Reviewers 96022-answering-reviewers.pdf
Audio Core Tip 96022-audio.mp3
Conflict-of-Interest Disclosure Form 96022-conflict-of-interest-statement.pdf
Copyright License Agreement 96022-copyright-assignment.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s) 96022-foundation-statement.pdf
Non-Native Speakers of English Editing Certificate 96022-non-native-speakers.pdf
Peer-review Report 96022-peer-reviews.pdf
Scientific Misconduct Check 96022-scientific-misconduct-check.png
Scientific Editor Work List 96022-scientific-editor-work-list.pdf
CrossCheck Report 96022-crosscheck-report.pdf